Status:
COMPLETED
Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome
Lead Sponsor:
Novartis
Conditions:
Hypertension, Dyslypidaemia
Eligibility:
All Genders
40-65 years
Phase:
PHASE4
Brief Summary
This study will evaluate the efficacy of a multi factorial preventive scheme of action (including fluvastatin and valsartan) to reduce the overall risk level in patients with metabolic syndrome.
Eligibility Criteria
Inclusion
- Age between 40 - 65 years
- Diagnosed metabolic syndrome
- Risk of cardiovascular death ≥ 5% (according to SCORE)
- Written informed consent
Exclusion
- Women not in menopause or not using efficient contraception
- Known hypersensitivity to study drugs
- History of ischemic heart disease
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT00821574
Start Date
July 1 2005
End Date
March 1 2007
Last Update
March 1 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.